RIBATAB Trademark

Trademark Overview

On Wednesday, May 31, 2017, a trademark application was filed for RIBATAB with the United States Patent and Trademark Office. The USPTO has given the RIBATAB trademark a serial number of 87469987. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 12, 2021. This trademark is owned by Abbvie Inc.. The RIBATAB trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of Hepatitis C
ribatab

General Information

Serial Number87469987
Word MarkRIBATAB
Filing DateWednesday, May 31, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 12, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 10, 2018

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of Hepatitis C

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 7, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbvie Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbvie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Monday, July 12, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 12, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 15, 2020EXTENSION 5 GRANTED
Tuesday, December 1, 2020EXTENSION 5 FILED
Tuesday, December 15, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 1, 2020TEAS EXTENSION RECEIVED
Tuesday, June 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 5, 2020EXTENSION 4 GRANTED
Friday, June 5, 2020EXTENSION 4 FILED
Friday, June 5, 2020TEAS EXTENSION RECEIVED
Thursday, November 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 26, 2019EXTENSION 3 GRANTED
Tuesday, November 26, 2019EXTENSION 3 FILED
Tuesday, November 26, 2019TEAS EXTENSION RECEIVED
Friday, June 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 5, 2019EXTENSION 2 GRANTED
Wednesday, June 5, 2019EXTENSION 2 FILED
Wednesday, June 5, 2019TEAS EXTENSION RECEIVED
Thursday, December 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 4, 2018EXTENSION 1 GRANTED
Tuesday, December 4, 2018EXTENSION 1 FILED
Tuesday, December 4, 2018TEAS EXTENSION RECEIVED
Tuesday, June 5, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 10, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 10, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 8, 2018ASSIGNED TO LIE
Friday, March 2, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 27, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 26, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 26, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 30, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 30, 2017NON-FINAL ACTION E-MAILED
Wednesday, August 30, 2017NON-FINAL ACTION WRITTEN
Tuesday, August 29, 2017ASSIGNED TO EXAMINER
Wednesday, June 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 3, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

ribatab hepatitis treatment preparations pharmaceutical